Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -193,757 | -97,352 | -328,937 | -226,445 | -145,515 |
| Depreciation Amortization | -212 | -276 | 1,203 | 1,393 | 619 |
| Accounts payable and accrued liabilities | -2,016 | 4,240 | -2,509 | 4,016 | 4,612 |
| Other Working Capital | -5,491 | -6,827 | 8,011 | 7,879 | 3,119 |
| Other Operating Activity | 37,322 | 13,332 | 57,788 | 27,818 | 16,112 |
| Operating Cash Flow | $-164,154 | $-86,883 | $-264,444 | $-185,339 | $-121,053 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -819 | -449 | -1,554 | -743 | -678 |
| Purchase Of Investment | -216,645 | -133,839 | -687,171 | -291,949 | -67,883 |
| Sale Of Investment | 195,287 | 97,831 | 289,199 | 215,935 | 146,850 |
| Investing Cash Flow | $-22,177 | $-36,457 | $-399,526 | $-76,757 | $78,289 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 272,391 | 49,291 | 49,291 |
| Debt Repayment | N/A | N/A | -54,635 | N/A | N/A |
| Common Stock Issued | 55,491 | 52,536 | 711,995 | 242,577 | 24,975 |
| Other Financing Activity | 0 | 0 | -51,518 | -2,304 | -2,069 |
| Financing Cash Flow | $55,491 | $52,536 | $878,233 | $289,564 | $72,197 |
| Beginning Cash Position | 312,428 | 312,428 | 98,165 | 98,165 | 98,165 |
| End Cash Position | 181,588 | 241,624 | 312,428 | 125,633 | 127,598 |
| Net Cash Flow | $-130,840 | $-70,804 | $214,263 | $27,468 | $29,433 |
| Free Cash Flow | |||||
| Operating Cash Flow | -164,154 | -86,883 | -264,444 | -185,339 | -121,053 |
| Capital Expenditure | -819 | -449 | -1,554 | -743 | -678 |
| Free Cash Flow | -164,973 | -87,332 | -265,998 | -186,082 | -121,731 |